Identification of Key Genes and Biological Pathways Related to Myocardial Infarction through Integrated

Nader Ebadi1,2, Reza Arefizadeh1, Mehrdad Nasrollahzadeh Sabet1

  • 1Department of Cardiology, School of Medicine, Aja University of Medical Sciences, Tehran, Iran.

Abstract

Insights

Bioinformatics analysis identified key genes and inflammation-related pathways in coronary heart disease (CHD) and myocardial infarction (MI). These findings offer potential biomarkers for diagnosing and treating CHD and MI.

Area of Science:

  • Cardiology
  • Bioinformatics
  • Genomics

Background:

  • Coronary heart disease (CHD) is a leading global cause of death.
  • Myocardial infarction (MI) is a severe manifestation of CHD.
  • Understanding CHD molecular mechanisms is crucial for developing new treatments.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying coronary heart disease (CHD).
  • To identify key deregulated genes and pathways in myocardial infarction (MI).
  • To discover potential biomarkers for CHD and MI diagnosis and therapy.

Main Methods:

  • Integrative bioinformatics analysis of three gene expression datasets (GSE19339, GSE66360, GSE29111).
  • Utilized the limma package in R for differential gene expression analysis.
  • Applied systems biology approaches to identify key pathways.

Main Results:

  • Identified 133 differentially expressed genes (DEGs), with KDM5D, EIF1AY, and CCL20 being highly upregulated.
  • Discovered five key signaling pathways implicated in the pathogenesis of CHD and MI.
  • The Interleukin-17 (IL-17) signaling pathway was identified as a potent factor.

Conclusions:

  • Five inflammation-related signaling pathways, including IL-17, were identified in MI and Coronary Artery Disease (CAD).
  • These pathways are crucial in the pathogenesis of MI and CAD.
  • The identified expression signatures and pathways can serve as potential biomarkers for diagnosis and therapeutic strategies.